Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Evoke Pharma (EVOK)
NASDAQ:EVOK
Holding EVOK?
Track your performance easily
EVOK Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.54 - $14.04
Previous Close$5.07
Volume53.24K
Average Volume (3M)391.28K
Market Cap
$7.53M
Enterprise Value$1.23M
Total Cash (Recent Filing)$11.30M
Total Debt (Recent Filing)$5.00M
Price to Earnings (P/E)―
Beta0.24
Next Earnings
Mar 05, 2025EPS Estimate
-$0.63Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-11.09
Shares Outstanding1,486,009
10 Day Avg. Volume56,667
30 Day Avg. Volume391,279
Standard Deviation0.25
R-Squared0.00107
Alpha-0.04
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)1.72
Price to Sales (P/S)0.87
Price to Cash Flow (P/CF)-2.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.14
Enterprise Value/Gross Profit0.25
Enterprise Value/Ebitda-0.22
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Evoke Pharma News
PremiumCompany Announcements
Evoke Pharma Reports Q3 2024 Financial Results
PremiumPre-Earnings
Is EVOK a Buy, Before Earnings?
PremiumCompany Announcements
Evoke Pharma Appoints Benjamin Smeal as DirectorRisk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
EVOK FAQ
What was Evoke Pharma’s price range in the past 12 months?
Evoke Pharma lowest stock price was $3.54 and its highest was $14.04 in the past 12 months.
What is Evoke Pharma’s market cap?
Currently, no data Available
When is Evoke Pharma’s upcoming earnings report date?
Evoke Pharma’s upcoming earnings report date is Mar 05, 2025 which is in 72 days.
How were Evoke Pharma’s earnings last quarter?
Evoke Pharma released its earnings results on Nov 07, 2024. The company reported -$0.94 earnings per share for the quarter, missing the consensus estimate of -$0.38 by -$0.56.
Is Evoke Pharma overvalued?
According to Wall Street analysts Evoke Pharma’s price is currently Overvalued.
Does Evoke Pharma pay dividends?
Evoke Pharma does not currently pay dividends.
What is Evoke Pharma’s EPS estimate?
Evoke Pharma’s EPS estimate is -$0.63.
How many shares outstanding does Evoke Pharma have?
Evoke Pharma has 1,486,009 shares outstanding.
What happened to Evoke Pharma’s price movement after its last earnings report?
Evoke Pharma reported an EPS of -$0.94 in its last earnings report, missing expectations of -$0.38. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Evoke Pharma?
Currently, no hedge funds are holding shares in EVOK
---
Evoke Pharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-61.93%
12-Months-Change
Fundamentals
Return on Equity
-349.91%
Trailing 12-Months
Asset Growth
80.23%
Trailing 12-Months
Company Description
Evoke Pharma
Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn, and David A. Gonyer in January 2007 and is headquartered in Solana Beach, CA.
---
EVOK Earnings Call
Q4 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a strong positive momentum for Evoke Pharma, highlighted by significant revenue growth, strategic advancements, and promising projections for 2024. However, the net loss and increased operational expenses remain areas of concern.Read More>---
Technical Analysis
---